-
-
NeuroLifeNow App
-
Posted in Industry News
-
23rd Feb 2021
-
New App and website to support people with neurological conditions
-
-
BIAL takes the lead with Zebinix®
-
Posted in Industry News
-
18th Feb 2021
-
News from Bial regarding marketing and distribution of Zebinix®
-
-
SPRAVATO® (esketamine nasal spray) authorised in Europe
-
Posted in Industry News
-
11th Feb 2021
-
News from Janssen Pharmaceutical Companies of Johnson & Johnson
-
-
Zeposia Tablets Approved in Scotland to Treat Active RRMS
-
Posted in Industry News
-
10th Feb 2021
-
New oral treatment for MS to be available in Scotland
-
-
Holography ‘quantum leap’ could revolutionise imaging
-
Posted in Industry News
-
08th Feb 2021
-
News from the University of Glasgow
-
-
Jazz Pharma adds cannabis-based drug to its portfolio
-
Posted in Industry News
-
04th Feb 2021
-
News from Jazz Pharmaceuticals
-
-
NICE rejects Ozanimod (Zeposia) for RRMS
-
Posted in Industry News
-
26th Jan 2021
-
New of NICE appraisal
-
-
Plegridy® intramuscular administration for RRMS
-
Posted in Industry News
-
22nd Dec 2020
-
News from Biogen
-
-
Free films capture life stories of people with dementia
-
Posted in Industry News
-
21st Dec 2020
-
30 free personalised films for people living with dementia
-
-
SPRAVATO®▼for the rapid reduction of depressive symptoms in a psychiatric emergency for patients with MDD
-
Posted in Industry News
-
16th Dec 2020
-
News from Janssen